{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T05:22:38Z","timestamp":1787030558457,"version":"build-2736575974"},"reference-count":25,"publisher":"Spandidos Publications","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp Ther Med"],"DOI":"10.3892\/etm.2017.5471","type":"journal-article","created":{"date-parts":[[2017,11,8]],"date-time":"2017-11-08T07:01:06Z","timestamp":1510124466000},"source":"Crossref","is-referenced-by-count":10,"title":["Rivaroxaban for the treatment of venous thromboembolism in patients with nephrotic syndrome and low AT\u2011III: A pilot study"],"prefix":"10.3892","author":[{"given":"Lihua","family":"Zhang","sequence":"first","affiliation":[{"name":"National Clinical Research Center of Kidney Disease, Jinling Hospital, Nanjing University School of Medicine, Nanjing, Jiangsu 210016, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haitao","family":"Zhang","sequence":"additional","affiliation":[{"name":"National Clinical Research Center of Kidney Disease, Jinling Hospital, Nanjing University School of Medicine, Nanjing, Jiangsu 210016, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiong","family":"Zhang","sequence":"additional","affiliation":[{"name":"National Clinical Research Center of Kidney Disease, Jinling Hospital, Nanjing University School of Medicine, Nanjing, Jiangsu 210016, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Tian","sequence":"additional","affiliation":[{"name":"National Clinical Research Center of Kidney Disease, Jinling Hospital, Nanjing University School of Medicine, Nanjing, Jiangsu 210016, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ju","family":"Liang","sequence":"additional","affiliation":[{"name":"National Clinical Research Center of Kidney Disease, Jinling Hospital, Nanjing University School of Medicine, Nanjing, Jiangsu 210016, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihong","family":"Liu","sequence":"additional","affiliation":[{"name":"National Clinical Research Center of Kidney Disease, Jinling Hospital, Nanjing University School of Medicine, Nanjing, Jiangsu 210016, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2017,11,8]]},"reference":[{"key":"key20200713143258_b1-etm-0-0-5471","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1055\/s-0037-1613887","article-title":"Incidence of venous thromboembolism: A community-based study in Western France. EPI-GETBP study group. Groupe d'Etude de la thrombose de bretagne occidentale","volume":"83","author":"Oger","year":"2000","journal-title":"Thromb Haemost"},{"key":"key20200713143258_b2-etm-0-0-5471","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1111\/j.1525-1497.2006.00458.x","article-title":"The worcester venous thromboembolism study: A population-based study of the clinical epidemiology of venous thromboembolism","volume":"21","author":"Spencer","year":"2006","journal-title":"J Gen Intern Med"},{"key":"key20200713143258_b3-etm-0-0-5471","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/ki.1985.149","article-title":"Hypercoagulability, renal vein thrombosis and other thrombotic complications of nephrotic syndrome","volume":"28","author":"Llach","year":"1985","journal-title":"Kidney Int"},{"key":"key20200713143258_b4-etm-0-0-5471","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1159\/000187205","article-title":"Membranous nephropathy and thromboembolism: Is prophylactic anticoagulation warranted?","volume":"63","author":"Bellomo","year":"1993","journal-title":"Nephron"},{"key":"key20200713143258_b5-etm-0-0-5471","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1038\/ki.2011.312","article-title":"Disease-specific risk of venous thromboembolic events is increased in idiopathic glomerulonephritis","volume":"81","author":"Barbour","year":"2012","journal-title":"Kidney Int"},{"key":"key20200713143258_b6-etm-0-0-5471","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1161\/CIRCULATIONAHA.107.716951","article-title":"High absolute risks and predictors of venous and arterial thromboembolic events in patients with nephrotic syndrome: Results from a large retrospective cohort study","volume":"117","author":"Mahmoodi","year":"2008","journal-title":"Circulation"},{"key":"key20200713143258_b7-etm-0-0-5471","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.thromres.2012.04.015","article-title":"Thromboembolic complications in membranous nephropathy patients with nephrotic syndrome-a prospective study","volume":"130","author":"Li","year":"2012","journal-title":"Thromb Res"},{"key":"key20200713143258_b8-etm-0-0-5471","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/0002-9343(78)90848-3","article-title":"Acuqired antithrombin III defiency and thrombosis in the nephrotic syndrome","volume":"65","author":"Kauffman","year":"1978","journal-title":"Am J Med"},{"key":"key20200713143258_b9-etm-0-0-5471","doi-asserted-by":"publisher","first-page":"401S","DOI":"10.1378\/chest.126.3_suppl.401S","article-title":"Antithrombotic therapy for venous thromboembolic disease: The seventh ACCP conference on antithrombotic and thrombolytic therapy","volume":"126","author":"B\u00fcller","year":"2004","journal-title":"Chest"},{"key":"key20200713143258_b10-etm-0-0-5471","first-page":"125","article-title":"Heparin resistance","volume":"9","author":"Bharadwaj","year":"2003","journal-title":"Lab Hematol"},{"key":"key20200713143258_b11-etm-0-0-5471","doi-asserted-by":"publisher","first-page":"2153","DOI":"10.1016\/j.athoracsur.2008.02.037","article-title":"Treating heparin resistance with antithrombin or fresh frozen plasma","volume":"85","author":"Spiess","year":"2008","journal-title":"Ann Thorac Surg"},{"key":"key20200713143258_b12-etm-0-0-5471","first-page":"319","article-title":"Prothrombotic factors in nephritic syndrome","volume":"43","author":"Saxena","year":"2000","journal-title":"Indian J Pathol Microbiol"},{"key":"key20200713143258_b13-etm-0-0-5471","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.clpt.2005.06.011","article-title":"Safety, pharmacodynamics, and pharmacokinetics of single doses of BAY 59\u20137939, an oral, direct factor Xa inhibitor","volume":"78","author":"Kubitza","year":"2005","journal-title":"Clin Pharmacol Ther"},{"key":"key20200713143258_b14-etm-0-0-5471","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1302\/0301-620X.91B5.21691","article-title":"Oral rivaroxaban for the prevention of symptomatic venous thromboembolism after elective hip and knee replacement","volume":"91","author":"Eriksson","year":"2009","journal-title":"J Bone Joint Surg Br"},{"key":"key20200713143258_b15-etm-0-0-5471","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1016\/S0140-6736(09)60734-0","article-title":"Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty (RECORD4): A randomised trial","volume":"373","author":"Turpie","year":"2009","journal-title":"Lancet"},{"key":"key20200713143258_b16-etm-0-0-5471","doi-asserted-by":"publisher","first-page":"2499","DOI":"10.1056\/NEJMoa1007903","article-title":"Oral rivaroxaban for symptomatic venous thromboembolism","volume":"363","author":"EINSTEIN Investigators","year":"2010","journal-title":"N Engl J Med"},{"key":"key20200713143258_b17-etm-0-0-5471","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1056\/NEJMoa1113572","article-title":"Oral rivaroxaban for the treatment of symptomatic pulmonary embolism","volume":"366","author":"EINSTEIN-PE Investigators","year":"2012","journal-title":"N Engl J Med"},{"key":"key20200713143258_b18-etm-0-0-5471","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.thromres.2013.04.016","article-title":"Impact of antithrombin deficiency on efficacy of edoxaban and antithrombin-dependent anticoagulants, fondaparinux, enoxaparin, and heparin","volume":"131","author":"Fukuda","year":"2013","journal-title":"Thromb Res"},{"key":"key20200713143258_b19-etm-0-0-5471","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s11948-000-0025-z","article-title":"Principles of good clinical practice (GCP) in clinical research","volume":"6","author":"Switula","year":"2000","journal-title":"Sci Eng Ethics"},{"key":"key20200713143258_b20-etm-0-0-5471","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1046\/j.1365-2257.2001.00410.x","article-title":"Evaluation of a new immunoturbidimetric test (LIATEST Antithrombin III) for determination of antithrombin antigen","volume":"23","author":"Antovic","year":"2001","journal-title":"Clin Lab Haem"},{"key":"key20200713143258_b21-etm-0-0-5471","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1111\/j.1538-7836.2004.00700.x","article-title":"Antithrombin antigen and activity in patients with acquired antithrombin deficiency-is there a difference?","volume":"2","author":"Ungerstedt","year":"2004","journal-title":"J Thromb Haemost"},{"key":"key20200713143258_b22-etm-0-0-5471","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.ejrad.2009.02.002","article-title":"Three-dimensional evaluation of chemotherapy response in malignant pleural mesothelioma","volume":"74","author":"Ak","year":"2010","journal-title":"Eur J Radiol"},{"key":"key20200713143258_b23-etm-0-0-5471","first-page":"407","article-title":"The assay and clinical significance of plasma antithrombin III in adult nephritic syndrome patients","volume":"19","author":"Tang","year":"2010","journal-title":"J Nephrol Dialy Transplant"},{"key":"key20200713143258_b24-etm-0-0-5471","first-page":"454","article-title":"Antithrombin III. Key factor in extracorporeal circulation","volume":"68","author":"Ranucci","year":"2002","journal-title":"Minerva Anestesiol"},{"key":"key20200713143258_b25-etm-0-0-5471","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1111\/j.1365-2141.1990.tb02541.x","article-title":"Antithrombin III and procoagulant activity: Sex differences and effects of the menopause","volume":"74","author":"Meade","year":"1990","journal-title":"Br J Haematol"}],"container-title":["Experimental and Therapeutic Medicine"],"original-title":[],"deposited":{"date-parts":[[2020,7,13]],"date-time":"2020-07-13T09:39:21Z","timestamp":1594633161000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/etm.2017.5471"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,8]]},"references-count":25,"URL":"https:\/\/doi.org\/10.3892\/etm.2017.5471","relation":{},"ISSN":["1792-0981","1792-1015"],"issn-type":[{"value":"1792-0981","type":"print"},{"value":"1792-1015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,8]]}}}